Betahistine Tablets
Developed to mitigate severe inner ear vertigo to support normal physical balance and alleviate dizziness symptoms.
- Categories
- Women's Health · Neurology
- Active ingredient
- Betahistine
- Route
- Oral use
- Form
- Tablet
- Strengths
- 8mg · 16mg · 24mg
The exact manufacturer offered is confirmed by the fulfilment partner before supply.
Prescription and consultation requirements for Betahistine Tablets vary by destination and are determined by the fulfilment partner.
Betahistine Tablets details
- Conditions
- Meniere's Disease · Vertigo
- Alternative names
- serc
- Therapeutic class
- Histaminergic Agonist
- Pharmacological class
- Vasodilator
- Contraindications
- pheochromocytoma; peptic ulcer disease
- Minor side effects
- nausea; indigestion; headache
- Moderate side effects
- mild bloating; pruritus; mild drowsiness
- Serious side effects
- anaphylaxis, requires immediate medical attention
- Dosage forms
- Tablet
- Administration route
- Oral use
- Supply category
- Prescription-only medicine (POM)
- Onset Time
- 1–2 weeks
- Duration
- 8–12 hours
- Storage instructions
- Store below 25°C.
- Drug interactions
- Antihistamines; MAO Inhibitors
- Age restrictions
- Approved for adults.
Patient summary
developed to mitigate severe inner ear vertigo to support normal physical balance and alleviate dizziness symptoms.
Mechanism of action
Acts as a weak H1 agonist and strong H3 antagonist, increasing blood circulation inside internal ear tissue structures.
Pregnancy and breastfeeding
TGA Category B: Safety in human pregnancies has not been established. Breastfeeding: Avoid.
What you will receive
Betahistine Tablets is a generic medicine sold under the name of its active ingredient, Betahistine, rather than under a brand.
- The fulfilment partner confirms the offered manufacturer and product before supply.
- Check the active ingredient, strength, form and pack shown at checkout before confirming an order.